AstraZeneca: announces $3.5bn investment in US

(CercleFinance.com) - AstraZeneca today announced a $3.
5bn investment in the US, aimed at expanding its research and production activities by the end of 2026.

The project includes $2bn to create more than a thousand highly skilled jobs, contributing to the growth of the US economy.

AstraZeneca plans to build a "state-of-the-art R&D center" in Massachusetts, a next-generation biotech manufacturing facility in Maryland, cell therapy production capacity on the West and East coasts, and specialty manufacturing in Texas.

By expanding our R&D and manufacturing activities, we aim to strengthen the development of cutting-edge therapies and support US leadership in healthcare innovation, AstraZeneca said.

These investments in the US mark the first steps towards AstraZeneca's ambition to generate $80bn in total sales by 2030, as announced last May.


Copyright (c) 2024 CercleFinance.com. All rights reserved.